Tag: Gedeon Richter

Biosimilar Teriparatide Launches in Europe by Gedeon Richter

A biosimilar to Eli Lilly’s Forsteo, biosimilar teriparatide, has been launched across Europe by Gedeon Richter following the patent expiration of the reference product, it was revealed on Aug. 20, 20...

Gedeon Richter, Hikma Pharmaceuticals Signed License Agreement to Commercialise Cariprazine

Hikma Pharmaceuticals, the multinational pharmaceutical company, and Gedeon Richter announced the signing of an exclusive license agreement to commercialise cariprazine, a novel antipsychotic,...

Gedeon Richter Underwrites $5mln Convertible Notes of Prima-Temp

Hungarian drugmaker Gedeon Richter said it has underwritten USD 5 million of convertible notes issued by Prima-Temp, a U.S. company that is developing a smart fertility sensor. Richter noted that i...

SID&GP inspectors participated in training GMP inspection

On October 8 and 9, inspectors of the SID&GP together with their peers from Armenia and Kazakhstan took part in a mock GMP inspection at the Gideon Richter Chemical Plant in Budapest (Hungary).

EMA accepted the resubmission for review of Neulasta biosimilar

STADA Arzneimittel AG was informed by Gedeon Richter Plc. that the European Medicines Agency (EMA) has accepted the regulatory resubmission of its proposed biosimilar to Amgen's Neulasta (pegfilgrastim).

Gedeon Richter-Rus invests 1.2 billion rubles to expand its facilities

gedeon richter
The Government of the Moscow region and CJSC Gedeon Richter-Rus signed an agreement to upgrade and expand the pharmaceutical production facilities